Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ischemic Heart Disease

  Free Subscription


20.05.2024

4 Am J Cardiol
1 Am J Med
1 Angiology
2 Ann Intern Med
10 Atherosclerosis
2 BMJ
1 Br J Haematol
1 Circ Cardiovasc Qual Outcomes
1 Circ Genom Precis Med
1 Circ Res
4 Circulation
1 Clin Chem
1 Crit Care Med
9 Eur Heart J
1 Hypertension
7 Int J Cardiol
12 J Am Coll Cardiol
1 J Clin Endocrinol Metab
2 J Mol Cell Cardiol
3 JAMA
1 Mayo Clin Proc
2 PLoS One
3 Prog Cardiovasc Dis


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. NISHINO M, Egami Y, Nakamura H, Abe M, et al
    Clinical Impact of Perfusion Balloon for ST-segment Elevated Myocardial Infarction: RYUSEI Study.
    Am J Cardiol. 2024 May 9:S0002-9149(24)00355.
    PubMed         Abstract available

  2. YAMAMOTO K, Shiomi H, Morimoto T, Miyazawa A, et al
    Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease and Diabetes.
    Am J Cardiol. 2024 May 11:S0002-9149(24)00335.
    PubMed         Abstract available

  3. SINGH S, Garg A, Tantry US, Bliden K, et al
    P2Y12 Inhibitor Monotherapy after Short Term Dual Antiplatelet Therapy in Acute Coronary Syndrome.
    Am J Cardiol. 2024 May 9:S0002-9149(24)00357.
    PubMed         Abstract available

  4. MAN LAM SH, Alam U, Lip GYH
    Cardiovascular and renal benefit of sodium-glucose co-transporter type 2 inhibitors in patients with Type 2 Diabetes.
    Am J Cardiol. 2024 May 9:S0002-9149(24)00340.
    PubMed        


    Am J Med

  5. LANG K, Chew C, De La Rosa M, Bertram AK, et al
    Performance of Cardiovascular Physical Exam Skills by Internal Medicine Residents.
    Am J Med. 2024 May 11:S0002-9343(24)00269-9. doi: 10.1016/j.amjmed.2024.
    PubMed         Abstract available


    Angiology

  6. OZBAY MB, Iqbal P, Perry JC, Degirmen S, et al
    Letter: Carvedilol vs Metoprolol: Mitigating Contrast-Induced Nephropathy in Acute Coronary Syndrome Patients.
    Angiology. 2024 May 14:33197241255170. doi: 10.1177/00033197241255170.
    PubMed        


    Ann Intern Med


  7. Annals Video Summary - Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men.
    Ann Intern Med. 2024 May 14:eM240479. doi: 10.7326/M24-0479.
    PubMed        

  8. YEAP BB, Marriott RJ, Dwivedi G, Adams RJ, et al
    Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men : Individual Participant Data Meta-analyses.
    Ann Intern Med. 2024 May 14. doi: 10.7326/M23-2781.
    PubMed         Abstract available


    Atherosclerosis

  9. SUGANE H, Asaumi Y, Ogata S, Kimura M, et al
    Evaluation of fractional flow reserve and atherosclerotic plaque characteristics on coronary non-contrast T1-weighted magnetic resonance imaging.
    Atherosclerosis. 2024;392:117530.
    PubMed         Abstract available

  10. JAIN V, Rifai MA, Kanaya AM, Shah NS, et al
    Association of cardiovascular health with subclinical coronary atherosclerosis progression among five racial and ethnic groups: The MASALA and MESA studies.
    Atherosclerosis. 2024;392:117522.
    PubMed         Abstract available

  11. PINXTERHUIS TH, Ploumen EH, van Vliet D, Gert van Houwelingen K, et al
    Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease.
    Atherosclerosis. 2024;392:117488.
    PubMed         Abstract available

  12. BERLOT AA, Fu X, Shea MK, Tracy R, et al
    Matrix Gla protein and the long-term incidence and progression of coronary artery and aortic calcification in the Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2024;392:117505.
    PubMed         Abstract available

  13. LARSSON J, Auscher S, Pararajasingam G, Heinsen LJ, et al
    Reply to: "Insulin resistance is an important index to assess glucose and insulin metabolism, but not a biological risk factor for high-risk coronary artery plaque composition".
    Atherosclerosis. 2024;392:117524.
    PubMed        

  14. ESCATE R, Padro T, Perez de Isla L, Fuentes F, et al
    Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients.
    Atherosclerosis. 2024;392:117502.
    PubMed         Abstract available

  15. RAZAVI AC, Raggi P, Whelton SP
    Coronary artery calcium: The canary in the coal mine.
    Atherosclerosis. 2024;392:117499.
    PubMed        

  16. BUGIARDINI R, Gulati M
    Closing the sex gap in cardiovascular mortality by achieving both horizontal and vertical equity.
    Atherosclerosis. 2024;392:117500.
    PubMed         Abstract available

  17. OBISESAN OH, Boakye E, Wang FM, Dardari Z, et al
    Coronary artery calcium as a marker of healthy and unhealthy aging in adults aged 75 and older: The Atherosclerosis Risk in Communities (ARIC) study.
    Atherosclerosis. 2024 Feb 13:117475. doi: 10.1016/j.atherosclerosis.2024.117475.
    PubMed         Abstract available

  18. BERISHA-MUHARREMI V, Majnaric-Trtica L, Mujaj B
    Insulin resistance is an important index to assess glucose and insulin metabolism, but not a biological risk factor for high-risk coronary artery plaque composition.
    Atherosclerosis. 2024;392:117484.
    PubMed        


    BMJ

  19. PALASKAS NL, Ali HJ, Koutroumpakis E, Ganatra S, et al
    Cardiovascular toxicity of immune therapies for cancer.
    BMJ. 2024;385:e075859.
    PubMed         Abstract available


  20. Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:q1094.
    PubMed        


    Br J Haematol

  21. ROGER G, Denormandie P, Gobe T, Azzolina D, et al
    Left ventricular global longitudinal strain and acute myocardial injury in patients with sickle cell disease admitted to the intensive care unit for vaso-occlusive crisis.
    Br J Haematol. 2024;204:2007-2015.
    PubMed         Abstract available


    Circ Cardiovasc Qual Outcomes

  22. APPLEFELD WN, Ford V, Cortes-Puch I, Wang J, et al
    Risks of Restrictive Versus Liberal Red Blood Cell Transfusion Strategies in Patients with Cardiovascular Disease: An Updated Meta-Analysis.
    Circ Cardiovasc Qual Outcomes. 2024 May 15. doi: 10.1161/CIRCOUTCOMES.124.010957
    PubMed        


    Circ Genom Precis Med

  23. VAN BLOKLAND IV, Oelen R, Groot HE, Benjamins JW, et al
    Single-Cell Dissection of the Immune Response After Acute Myocardial Infarction.
    Circ Genom Precis Med. 2024 May 16:e004374. doi: 10.1161/CIRCGEN.123.004374.
    PubMed         Abstract available


    Circ Res

  24. JIANG J, Hiron TK, Agbaedeng T, Malhotra Y, et al
    A Novel Macrophage Subpopulation Conveys Increased Genetic Risk of Coronary Artery Disease.
    Circ Res. 2024 May 15. doi: 10.1161/CIRCRESAHA.123.324172.
    PubMed         Abstract available


    Circulation

  25. TANG WHW, Hazen SL
    Unraveling the Complex Relationship Between Gut Microbiome and Cardiovascular Diseases.
    Circulation. 2024;149:1543-1545.
    PubMed        


  26. Correction to: An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
    Circulation. 2024;149:e1189-e1190.
    PubMed        

  27. COLLET C, Munhoz D, Mizukami T, Sonck J, et al
    Influence of Pathophysiological Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes.
    Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.069450.
    PubMed         Abstract available

  28. BULLUCK H, Chong JH, Bryant J, Annathurai A, et al
    Effect of Cangrelor on Infarct Size in ST-Segment Elevation Myocardial Infarction Treated By Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial).
    Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.068938.
    PubMed         Abstract available


    Clin Chem

  29. KOBA S, Satoh N, Ito Y, Yokota Y, et al
    Impact of Direct Measurement of Small Dense Low-Density Lipoprotein Cholesterol for Long-Term Secondary Prevention in Patients with Stable Coronary Artery Disease.
    Clin Chem. 2024 May 17:hvae061. doi: 10.1093.
    PubMed         Abstract available


    Crit Care Med

  30. ARAI R, Murata N, Fukamachi D, Okumura Y, et al
    Current Use and Impact of Pulmonary Artery Catheters on the Short-Term Outcomes in Patients With Cardiogenic Shock Treated With an Impella: Findings From the Japan Registry for Percutaneous Ventricular Assist Device (J-PVAD).
    Crit Care Med. 2024;52:e279-e288.
    PubMed         Abstract available


    Eur Heart J

  31. PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al
    Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
    Eur Heart J. 2024 May 14:ehae266. doi: 10.1093.
    PubMed         Abstract available

  32. CREA F
    Focus on ischaemic heart disease: prevention with colchicine, role of the brain-heart axis, new therapeutic targets for ischaemia-reperfusion injury.
    Eur Heart J. 2024;45:1577-1581.
    PubMed        

  33. TAKAHARA M, Soga Y, Iida O
    Lower extremity arterial disease vs. coronary artery disease: mortality differences after revascularization.
    Eur Heart J. 2024;45:1634-1643.
    PubMed         Abstract available

  34. AMPONSAH-OFFEH M, Tual-Chalot S, Stellos K
    Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury.
    Eur Heart J. 2024;45:1681-1683.
    PubMed        

  35. YANG K, Gao R, Chen H, Hu J, et al
    Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition.
    Eur Heart J. 2024;45:1662-1680.
    PubMed         Abstract available

  36. ADLAM D, van Dijk FS, Loeys B
    Genetic testing in patients with unexplained coronary aneurysms or dilation.
    Eur Heart J. 2024;45:1610-1612.
    PubMed        

  37. JONES DA, Beirne AM, Kelham M, Wynne L, et al
    Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
    Eur Heart J. 2024;45:1647-1658.
    PubMed         Abstract available

  38. URSO S, Sadaba R, Dayan V
    Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
    Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
    PubMed        

  39. XIAO Q, Xu Y, Wang S
    Gastropericardial fistula complicated by severe multi-vessel coronary spasm.
    Eur Heart J. 2024;45:1685.
    PubMed        


    Hypertension

  40. SHEN Y, Hu G
    Gestational Diabetes Mellitus and Postpartum Hypertension: Evidence for a Tight Linkage Toward Women's Cardiovascular Health.
    Hypertension. 2024;81:1269-1271.
    PubMed        


    Int J Cardiol

  41. SMITH SW, Meyers HP
    ST Elevation is a poor surrogate for acute coronary occlusion. Let's Replace STEMI with Occlusion MI (OMI)!!
    Int J Cardiol. 2024;407:131980.
    PubMed        

  42. PETERSEN JK, Butt JH, Yafasova A, Torp-Pedersen C, et al
    Prognosis and antithrombotic practice patterns in patients with recurrent and transient atrial fibrillation following acute coronary syndrome: A nationwide study.
    Int J Cardiol. 2024 Apr 6:132017. doi: 10.1016/j.ijcard.2024.132017.
    PubMed         Abstract available

  43. GROEN RA, Barbero FL, Fischer SE, van Dijkman PRM, et al
    Coronary artery calcium assessment on non-gated chest CT to optimize pre-operative cardiac screening in liver transplantation.
    Int J Cardiol. 2024;407:132015.
    PubMed         Abstract available

  44. GOLD DA, Sandesara PB, Kindya B, Gold ME, et al
    Circulating Progenitor Cells and Coronary Collaterals in Chronic Total Occlusion.
    Int J Cardiol. 2024;407:132104.
    PubMed         Abstract available

  45. SAARINEN SL, Borregaard B, Ekholm O, Christensen AV, et al
    Self-reported mental and physical health is associated with not returning to work in patients with ischemic heart disease.
    Int J Cardiol. 2024 May 15:132180. doi: 10.1016/j.ijcard.2024.132180.
    PubMed         Abstract available

  46. CANDREVA A, Buongiorno AL, Matter MA, Rizzini ML, et al
    Impact of endothelial shear stress on coronary atherosclerotic plaque progression and composition: A meta-analysis and systematic review.
    Int J Cardiol. 2024;407:132061.
    PubMed         Abstract available

  47. JONG CB, Lu TS, Chen JW
    Reply to comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
    Int J Cardiol. 2024 Apr 10:132031. doi: 10.1016/j.ijcard.2024.132031.
    PubMed        


    J Am Coll Cardiol

  48. OSTROMINSKI JW, Claggett BL, Miao ZM, Mc Causland FR, et al
    Cardiovascular-Kidney-Metabolic Overlap in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Trial-Level Analysis.
    J Am Coll Cardiol. 2024 May 9:S0735-1097(24)07204.
    PubMed        

  49. SHAPIRO MD, German CA
    Early Inclisiran Use in Atherosclerotic Cardiovascular Disease: Overcoming Therapeutic Inertia.
    J Am Coll Cardiol. 2024;83:1953-1956.
    PubMed        

  50. LI M, Ren L, He L, Lai Y, et al
    Small Left Ventricle in Patients With Atrial Fibrillation Is Associated With Increased Cardiovascular Risk.
    J Am Coll Cardiol. 2024;83:1957-1969.
    PubMed         Abstract available

  51. HUNG CL, Yang NI, Chiang CE
    Cardiovascular Risk Stratification by LV Size Among AF Population: Smaller Is Not Always Better.
    J Am Coll Cardiol. 2024;83:1970-1972.
    PubMed        

  52. SINHA A, Rahman H, Perera D
    Reply: Rethinking False Positive Exercise Electrocardiographic Stress Tests by Assessing Coronary Microvascular Function.
    J Am Coll Cardiol. 2024;83:e195-e196.
    PubMed        

  53. SANTOS-PARDO I, Andersson Franko M, Lagerqvist B, Ritsinger V, et al
    Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2024 May 7:S0735-1097(24)06933.
    PubMed         Abstract available

  54. RAJKUMAR CA, Foley MJ, Ahmed-Jushuf F, Simader FA, et al
    N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2024 May 8:S0735-1097(24)06824.
    PubMed         Abstract available

  55. SIMADER FA, Rajkumar CA, Foley MJ, Ahmed-Jushuf F, et al
    Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2024 May 10:S0735-1097(24)06948.
    PubMed         Abstract available

  56. ALI ZA, Landmesser U, Maehara A, Shin D, et al
    OCT-Guided versus Angiography-Guided Coronary Stent Implantation in Complex Lesions: An ILUMIEN IV Substudy.
    J Am Coll Cardiol. 2024 May 6:S0735-1097(24)07085.
    PubMed         Abstract available

  57. DIMITRIADIS K, Pyrpyris N, Tsioufis K
    Exercise Electrocardiographic Stress Test for Diagnosing Coronary Microvascular Dysfunction: Tale as Old as Time?
    J Am Coll Cardiol. 2024;83:e189.
    PubMed        

  58. MINER SES, Blair JA, McCarthy MC, Nield LE, et al
    The Complex and Incomplete Relationship Between Exercise Stress Testing and Coronary Microvascular Dysfunction.
    J Am Coll Cardiol. 2024;83:e193-e194.
    PubMed        

  59. EERDEKENS R, El Farissi M, De Maria GL, van Royen N, et al
    Prognostic Value of Microvascular Resistance Reserve After Percutaneous Coronary Intervention in Patients With Myocardial Infarction.
    J Am Coll Cardiol. 2024 May 3:S0735-1097(24)06759.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  60. KAWAGUCHI H
    Letter to the Editor from Kawaguchi: 'Cardiovascular Safety of Romosozumab vs. PTH Analogs for Osteoporosis Treatment: a Propensity Score Matched Cohort Study'.
    J Clin Endocrinol Metab. 2024 May 18:dgae347. doi: 10.1210.
    PubMed        


    J Mol Cell Cardiol

  61. MCCALLINHART PE, Chade AR, Bender SB, Trask AJ, et al
    Expanding landscape of coronary microvascular disease in co-morbid conditions: Metabolic disease and beyond.
    J Mol Cell Cardiol. 2024;192:26-35.
    PubMed         Abstract available

  62. DE WINTER N, Ji J, Sintou A, Forte E, et al
    Persistent transcriptional changes in cardiac adaptive immune cells following myocardial infarction: New evidence from the re-analysis of publicly available single cell and nuclei RNA-sequencing data sets.
    J Mol Cell Cardiol. 2024;192:48-64.
    PubMed         Abstract available


    JAMA

  63. SELVARAJ S, Claggett B, Shah SH, Mentz RJ, et al
    Cardiovascular Burden of the V142I Transthyretin Variant.
    JAMA. 2024 May 12:e244467. doi: 10.1001/jama.2024.4467.
    PubMed         Abstract available

  64. GAZIANO TA, Gaziano JM
    Can Cardiovascular Risk Assessment Be Improved in the 21st Century?
    JAMA. 2024 May 13. doi: 10.1001/jama.2024.7644.
    PubMed        

  65. NEUMANN JT, Twerenbold R, Weimann J, Ballantyne CM, et al
    Prognostic Value of Cardiovascular Biomarkers in the Population.
    JAMA. 2024 May 13:e245596. doi: 10.1001/jama.2024.5596.
    PubMed         Abstract available


    Mayo Clin Proc

  66. BHATTA DN, Bommer W
    Trends in California Cardiovascular Disease Mortality: Sex-Race/Ethnicity Disparity and Income Inequality.
    Mayo Clin Proc. 2024 May 13:S0025-6196(24)00104.
    PubMed         Abstract available


    PLoS One

  67. RUMIZ E, Valero E, Fernandez C, Vilar JV, et al
    In-hospital versus after-discharge complete revascularization in patients with ST segment elevation myocardial infarction and multivessel disease. REVIVA-ST trial.
    PLoS One. 2024;19:e0303284.
    PubMed         Abstract available

  68. ANDRUP S, Andersen GO, Hoffmann P, Eritsland J, et al
    Novel cardiac extracellular matrix biomarkers in STEMI: Associations with ischemic injury and long-term mortality.
    PLoS One. 2024;19:e0302732.
    PubMed         Abstract available


    Prog Cardiovasc Dis

  69. GOMEZ S, Dudum R, Rodriguez F
    Inequities in atherosclerotic cardiovascular disease prevention.
    Prog Cardiovasc Dis. 2024 May 9:S0033-0620(24)00071.
    PubMed         Abstract available

  70. MANUBOLU VS, Ichikawa K, Budoff MJ
    Innovations in cardiac computed tomography: Imaging in coronary artery disease.
    Prog Cardiovasc Dis. 2024 May 14:S0033-0620(24)00073.
    PubMed         Abstract available

  71. SOROOSH GP, Tasdighi E, Adhikari R, Blaha MJ, et al
    Coronary artery calcium in 2023: Guidelines for LDL-C goals, non-statin therapies, and aspirin use.
    Prog Cardiovasc Dis. 2024 May 14:S0033-0620(24)00072.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.